Cargando…
The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one
For over 3.5 years, SARS CoV-2 is continuing to evolve threatening to return all and any improvement the world has made into square one. In this clinically oriented systematic review and perspective, the author explains how the best current medical evidence is strongly supporting the use of the low...
Autor principal: | Kelleni, Mina T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691980/ https://www.ncbi.nlm.nih.gov/pubmed/37326756 http://dx.doi.org/10.1007/s10787-023-01263-4 |
Ejemplares similares
-
Real-life practice of the Egyptian Kelleni's protocol in the current tripledemic: COVID-19, RSV and influenza
por: Kelleni, Mina T.
Publicado: (2022) -
NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
por: Kelleni, Mina T.
Publicado: (2021) -
Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management
por: Kelleni, Mina T.
Publicado: (2020) -
Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus
por: Schultz, Denise A., et al.
Publicado: (2009) -
Real-world practice of the Egyptian Kelleni’s protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol
por: Kelleni, Mina T.
Publicado: (2023)